Cargando…
DNA methylation and demethylation as targets for antipsychotic therapy
Schizophrenia (SZ) and bipolar disorder (BPD) patients show a downregulation of GAD67, reelin (RELN), brain-derived neurotrophic factor (BDNF), and other genes expressed in telencephalic GABAergic and glutamatergic neurons. This downregulation is associated with the enrichment of 5-methylcytosine an...
Autores principales: | Guidotti, Alessandro, Grayson, Dennis R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214182/ https://www.ncbi.nlm.nih.gov/pubmed/25364290 |
Ejemplares similares
-
Developments in antipsychotic therapy with regard to hypotheses for schizophrenia
por: Ackenheil, Manfred, et al.
Publicado: (2002) -
Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects
por: Ackenheil, Manfred, et al.
Publicado: (2004) -
Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014) -
Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009) -
Inhibition of the reward system by antipsychotic treatment
por: Juckel, Georg
Publicado: (2016)